Cargando…

A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy

INTRODUCTION: An incremental approach using open-triple therapy may improve outcomes in patients with chronic obstructive pulmonary disease (COPD). However, there is little sufficient, real-world evidence available identifying time to open-triple initiation. METHODS: This retrospective study of pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mapel, Douglas, Laliberté, François, Roberts, Melissa H, Sama, Susan R, Sundaresan, Devi, Pilon, Dominic, Lefebvre, Patrick, Duh, Mei Sheng, Patel, Jeetvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485896/ https://www.ncbi.nlm.nih.gov/pubmed/28684905 http://dx.doi.org/10.2147/COPD.S129007

Ejemplares similares

Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population
por: Law, Amy, et al.
Publicado: (2016)

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
por: Bogart, Michael, et al.
Publicado: (2019)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
por: Roberts, Melissa H., et al.
Publicado: (2019)

Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research
por: Mapel, Douglas W., et al.
Publicado: (2014)

Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Mapel, Douglas W, et al.
Publicado: (2021)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
por: Bengtson, Lindsay G.S., et al.
Publicado: (2018)

A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Huang, Wei-Chun, et al.
Publicado: (2021)

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
por: Bogart, Michael, et al.
Publicado: (2023)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
por: Dalal, Anand A, et al.
Publicado: (2011)

Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2013)

Adjuvant vitamin C for sepsis: mono or triple?
por: Spoelstra–de Man, Angelique M. E., et al.
Publicado: (2019)

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
por: Roberts, Melissa H, et al.
Publicado: (2015)

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
por: Slade, David, et al.
Publicado: (2021)

ACT-26 PATTERN OF RECURRENCE IN NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH PHOTODYNAMIC THERAPY
por: Nakayama, Noriyuki, et al.
Publicado: (2022)

Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States
por: Kan, Hong, et al.
Publicado: (2014)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

Erratum: Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis
Publicado: (2021)

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line
por: Shi, Chaoji, et al.
Publicado: (2022)

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study
por: Slade, David, et al.
Publicado: (2021)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Risperidone Mono - Therapy as Prophylaxis in Bipolar Affective Disorders
por: Trivedi, Mohit, et al.
Publicado: (2004)

Newly Discovered Cutting-Edge Triple Combination Cystic Fibrosis Therapy: A Systematic Review
por: Dawood, Sarah N, et al.
Publicado: (2022)

Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014)

Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study
por: Sama, Susan R., et al.
Publicado: (2023)

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study
por: Alberts, Mark, et al.
Publicado: (2023)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
por: Misra, Ranjita, et al.
Publicado: (2021)

Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
por: Zhdanava, Maryia, et al.
Publicado: (2022)

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
por: Bogart, Michael, et al.
Publicado: (2023)

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?
por: Lingvay, Ildiko, et al.
Publicado: (2009)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022)

Evaluation of the Efficacy of Combined Therapy of Methotrexate and Etanercept versus Methotrexate as a Mono-Therapy
por: Rexhepi, Sylejman, et al.
Publicado: (2018)

Mono- and combinational drug therapies for global viral pandemic preparedness
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
por: Zheng, Yayuan, et al.
Publicado: (2018)

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pir4vpt3id1ohmm02g4sasfqpo